Giant axonal neuropathy: studies with sulfhydryl donor compounds

Rup Tandan, Walter G. Bradley, Michael J. Fillyaw

Research output: Contribution to journalArticle

7 Scopus citations

Abstract

Giant axonal neuropathy (GAN) is a disorder characterized pathologically by distal neurofilament-filled bulbous swellings in axons, and widespread collection of intermediate filaments, including masses of vimentin filaments in cultured skin fibroblasts. A morphologically similar neurofibrillary disorder is produced by acrylamide and the toxic hexacarbons, agents which bind to thiol groups. We report, in GAN fibroblasts, inhibition of vimentin filament aggregation by dithiothreitol and penicillamine, sulfhydryl donor compounds which stabilize thiols. In addition, we describe clinical improvement in a GAN patient treated with penicillamine, despite earlier progressive disease. These findings support the hypothesis of disordered thiol metabolism in GAN, and open up avenues for further research.

Original languageEnglish (US)
Pages (from-to)153-162
Number of pages10
JournalJournal of the Neurological Sciences
Volume95
Issue number2
DOIs
StatePublished - Feb 1990
Externally publishedYes

Keywords

  • Dithiothreitol
  • Fibroblasts
  • Giant axonal neuropathy
  • Glutathione
  • Penicillamine
  • Vimentin filaments

ASJC Scopus subject areas

  • Aging
  • Clinical Neurology
  • Surgery
  • Neuroscience(all)
  • Developmental Neuroscience
  • Neurology

Fingerprint Dive into the research topics of 'Giant axonal neuropathy: studies with sulfhydryl donor compounds'. Together they form a unique fingerprint.

  • Cite this